Stock Analyzer | Investment Intelligence

Price

24.5 USD

close · 30.10.2026 (America/New_York)

Change vs previous close

-1.4%

Close, 2Y: 31.10.2024 18.06 → 30.10.2026 24.5 (+35.7%), min 15.54, max 31.48

Data: partial

ADR: P/B and multiples by year unavailable (receipt ≠ share)

Valuation · Reporting currency: GBP

P/E

17.1

P/S

2.2

EV/EBITDA

—

FCF yield

+7.3%

GSK plc